{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:54:50Z","timestamp":1787003690806,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Post-acute sequelae SARS-CoV-2 (PASC), also known as Long COVID, is a complex and widely recognized illness with estimates ranging from 5 to 30% of all COVID-19 cases. We performed a retrospective chart review of patients who presented to a dedicated Post-COVID-19 clinic between June 2021 and May 2022. The median patient age was 44.5 years, 63.5% patients were female, and patients presented at a median of 10.4 months from acute COVD-19 infection. 78% self-identified their race as white, and 21% identified as Latino ethnicity. During the acute COVID-19 infection, 50% of patients experienced moderate disease severity and 10.5% were hospitalized. The top three co-morbid conditions prior to SARS-CoV-2 infection included mental health conditions, hypertension and asthma. Patients reported a median of 18 new symptoms following COVID-19 illness, the most common were fatigue (89%), forgetfulness or \u201cbrain fog\u201d (89%), and difficulty concentrating (77%). MoCA (Montreal Cognitive Assessment) assessment demonstrated that 46% had mild cognitive dysfunction. PHQ-9 (Patient Health Questionnaire) testing revealed 42% had moderate to severe depression, and 38% had moderate to severe anxiety on the GAD-7 (Generalized Anxiety Disorder) assessment. Symptom burden was similar across gender, age, and initial disease severity. PASC patients presenting to an academic Post-COVID-19 clinic experienced numerous multisystem symptoms and functional impairment, independent of the initial COVID-19 disease severity.<\/jats:p>","DOI":"10.1038\/s41598-023-48502-w","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T13:02:13Z","timestamp":1702299733000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Clinical characteristics of Long COVID patients presenting to a dedicated academic post-COVID-19 clinic in Central Texas"],"prefix":"10.1038","volume":"13","author":[{"given":"Rija","family":"Aziz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Siles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Wylie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Melamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Michael","family":"Brode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,11]]},"reference":[{"key":"48502_CR1","unstructured":"Long COVID or post-COVID conditions. CDC https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/long-term-effects\/index.html (2022)."},{"key":"48502_CR2","doi-asserted-by":"crossref","unstructured":"Lara Bull-Otterson, PhD. et al. Post\u2013COVID conditions among adult COVID-19 survivors aged 18\u201364 and \u226565 Years \u2014 United States. CDC https:\/\/www.cdc.gov\/mmwr\/volumes\/71\/wr\/mm7121e1.htm (2022).","DOI":"10.15585\/mmwr.mm7121e1"},{"key":"48502_CR3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.0830","volume":"4","author":"JK Logue","year":"2021","unstructured":"Logue, J. K. et al. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw. Open 4, e210830. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.0830 (2021).","journal-title":"JAMA Netw. Open"},{"key":"48502_CR4","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.38804","volume":"5","author":"RH Perlis","year":"2022","unstructured":"Perlis, R. H. et al. Prevalence and correlates of long COVID symptoms among US adults. JAMA Netw. Open 5, e2238804. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.38804 (2022).","journal-title":"JAMA Netw. Open"},{"key":"48502_CR5","doi-asserted-by":"publisher","first-page":"6571","DOI":"10.1038\/s41467-021-26513-3","volume":"12","author":"Y Xie","year":"2021","unstructured":"Xie, Y., Bowe, B. & Al-Aly, Z. Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status. Nat. Commun. 12, 6571. https:\/\/doi.org\/10.1038\/s41467-021-26513-3 (2021).","journal-title":"Nat. Commun."},{"key":"48502_CR6","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0140-6736(20)32656-8","volume":"397","author":"C Huang","year":"2021","unstructured":"Huang, C. et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 397, 220\u2013232. https:\/\/doi.org\/10.1016\/S0140-6736(20)32656-8 (2021).","journal-title":"Lancet"},{"key":"48502_CR7","unstructured":"A clinical case definition of post COVID-19 condition by a Delphi consensus. WHO https:\/\/www.who.int\/publications-detail-redirect\/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 (2021)."},{"key":"48502_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101019","volume":"38","author":"HE Davis","year":"2021","unstructured":"Davis, H. E. et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 38, 101019. https:\/\/doi.org\/10.1016\/j.eclinm.2021.101019 (2021).","journal-title":"EClinicalMedicine"},{"key":"48502_CR9","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.28568","volume":"4","author":"D Groff","year":"2021","unstructured":"Groff, D. et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: A systematic review. JAMA Netw. Open 4, e2128568. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.28568 (2021).","journal-title":"JAMA Netw. Open"},{"key":"48502_CR10","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/S0140-6736(22)00941-2","volume":"399","author":"M Antonelli","year":"2022","unstructured":"Antonelli, M., Pujol, J. C., Spector, T. D., Ourselin, S. & Steves, C. J. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet 399, 2263\u20132264. https:\/\/doi.org\/10.1016\/S0140-6736(22)00941-2 (2022).","journal-title":"Lancet"},{"key":"48502_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101624","volume":"53","author":"KI Notarte","year":"2022","unstructured":"Notarte, K. I. et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. EClinicalMedicine 53, 101624. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101624 (2022).","journal-title":"EClinicalMedicine"},{"key":"48502_CR12","doi-asserted-by":"publisher","first-page":"ofac464","DOI":"10.1093\/ofid\/ofac464","volume":"9","author":"D Ayoubkhani","year":"2022","unstructured":"Ayoubkhani, D. et al. Risk of long COVID in people infected with severe acute respiratory syndrome coronavirus 2 after 2 doses of a coronavirus disease 2019 vaccine: Community-based, matched cohort study. Open Forum Infect. Dis. 9, ofac464. https:\/\/doi.org\/10.1093\/ofid\/ofac464 (2022).","journal-title":"Open Forum Infect. Dis."},{"key":"48502_CR13","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/s41591-022-01840-0","volume":"28","author":"Z Al-Aly","year":"2022","unstructured":"Al-Aly, Z., Bowe, B. & Xie, Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 28, 1461\u20131467. https:\/\/doi.org\/10.1038\/s41591-022-01840-0 (2022).","journal-title":"Nat. Med."},{"key":"48502_CR14","unstructured":"Bach, K. Is \u2018long Covid\u2019 worsening the labor shortage? Brookings https:\/\/www.brookings.edu\/research\/is-long-covid-worsening-the-labor-shortage (2022)."},{"key":"48502_CR15","unstructured":"Post-COVID Care Centers. SurvivorCorps post-COVID care centers\u2014survivor corps (2023)."},{"key":"48502_CR16","unstructured":"Ladyzhets, B. Where are the long COVID clinics? ScienceNews https:\/\/www.sciencenews.org\/article\/long-covid-clinics-map-locations-prevalence. (2022)."},{"key":"48502_CR17","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/j.mayocp.2021.04.024","volume":"96","author":"G Vanichkachorn","year":"2021","unstructured":"Vanichkachorn, G. et al. Post-COVID-19 syndrome (long haul syndrome): Description of a multidisciplinary clinic at mayo clinic and characteristics of the initial patient cohort. Mayo Clin. Proc. 96, 1782\u20131791. https:\/\/doi.org\/10.1016\/j.mayocp.2021.04.024 (2021).","journal-title":"Mayo Clin. Proc."},{"key":"48502_CR18","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1002\/acn3.51570","volume":"9","author":"ST Ali","year":"2022","unstructured":"Ali, S. T. et al. Evolution of neurologic symptoms in non-hospitalized COVID-19 \u201clong haulers\u201d. Ann. Clin. Transl. Neurol. 9, 950\u2013961. https:\/\/doi.org\/10.1002\/acn3.51570 (2022).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"48502_CR19","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.40985","volume":"5","author":"O Robineau","year":"2022","unstructured":"Robineau, O. et al. Long-lasting symptoms after an acute COVID-19 infection and factors associated with their resolution. JAMA Netw. Open 5, e2240985. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.40985 (2022).","journal-title":"JAMA Netw. Open"},{"key":"48502_CR20","unstructured":"Underlying medical conditions associated with higher risk for severe COVID-19: Information for Healthcare Professionals. CDC Underlying Medical Conditions Associated with Higher Risk for Severe COVID-19: Information for Healthcare Professionals|CDC (2023)."},{"key":"48502_CR21","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/acn3.51578","volume":"9","author":"JE Shanley","year":"2022","unstructured":"Shanley, J. E. et al. Longitudinal evaluation of neurologic-post acute sequelae SARS-CoV-2 infection symptoms. Ann. Clin. Transl. Neurol. 9, 995\u20131010. https:\/\/doi.org\/10.1002\/acn3.51578 (2022).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"48502_CR22","doi-asserted-by":"publisher","first-page":"1604501","DOI":"10.3389\/phrs.2022.1604501","volume":"43","author":"V Nittas","year":"2022","unstructured":"Nittas, V. et al. Long COVID through a public health lens: An umbrella review. Public Health Rev. 43, 1604501. https:\/\/doi.org\/10.3389\/phrs.2022.1604501 (2022).","journal-title":"Public Health Rev."},{"key":"48502_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/life12071066","author":"A Mumtaz","year":"2022","unstructured":"Mumtaz, A. et al. COVID-19 vaccine and long COVID: A scoping review. Life (Basel) https:\/\/doi.org\/10.3390\/life12071066 (2022).","journal-title":"Life (Basel)"},{"key":"48502_CR24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","volume":"21","author":"HE Davis","year":"2023","unstructured":"Davis, H. E., McCorkell, L., Vogel, J. M. & Topol, E. J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 21, 133\u2013146. https:\/\/doi.org\/10.1038\/s41579-022-00846-2 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"48502_CR25","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1365-2796.2011.02428.x","volume":"270","author":"BM Carruthers","year":"2011","unstructured":"Carruthers, B. M. et al. Myalgic encephalomyelitis: International consensus criteria. J. Intern. Med. 270, 327\u2013338. https:\/\/doi.org\/10.1111\/j.1365-2796.2011.02428.x (2011).","journal-title":"J. Intern. Med."},{"key":"48502_CR26","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s40520-021-02042-3","volume":"34","author":"V Cristillo","year":"2022","unstructured":"Cristillo, V. et al. Premorbid vulnerability and disease severity impact on long-COVID cognitive impairment. Aging Clin. Exp. Res. 34, 257\u2013260. https:\/\/doi.org\/10.1007\/s40520-021-02042-3 (2022).","journal-title":"Aging Clin. Exp. Res."},{"key":"48502_CR27","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1002\/alz.12644","volume":"18","author":"L Crivelli","year":"2022","unstructured":"Crivelli, L. et al. Changes in cognitive functioning after COVID-19: A systematic review and meta-analysis. Alzheimers Dement. 18, 1047\u20131066. https:\/\/doi.org\/10.1002\/alz.12644 (2022).","journal-title":"Alzheimers Dement."},{"key":"48502_CR28","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMcibr2210069","volume":"387","author":"V Venkataramani","year":"2022","unstructured":"Venkataramani, V. & Winkler, F. Cognitive deficits in long covid-19. N. Engl. J. Med. 387, 1813\u20131815. https:\/\/doi.org\/10.1056\/NEJMcibr2210069 (2022).","journal-title":"N. Engl. J. Med."},{"key":"48502_CR29","doi-asserted-by":"publisher","first-page":"5795","DOI":"10.1007\/s10072-022-06285-4","volume":"43","author":"V Cristillo","year":"2022","unstructured":"Cristillo, V. et al. Predictors of \u201cbrain fog\u201d 1 year after COVID-19 disease. Neurol. Sci. 43, 5795\u20135797. https:\/\/doi.org\/10.1007\/s10072-022-06285-4 (2022).","journal-title":"Neurol. Sci."},{"key":"48502_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph191811316","author":"M Hazumi","year":"2022","unstructured":"Hazumi, M., Usuda, K., Okazaki, E., Kataoka, M. & Nishi, D. Differences in the course of depression and anxiety after COVID-19 infection between recovered patients with and without a psychiatric history: A cross-sectional study. Int. J. Environ. Res. Public Health https:\/\/doi.org\/10.3390\/ijerph191811316 (2022).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"48502_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03328-4","author":"M Rojas","year":"2022","unstructured":"Rojas, M. et al. Autoimmunity is a hallmark of post-COVID syndrome. J. Transl. Med. https:\/\/doi.org\/10.1186\/s12967-022-03328-4 (2022).","journal-title":"J. Transl. Med."},{"key":"48502_CR32","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00970-2022","author":"K Son","year":"2023","unstructured":"Son, K. et al. Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms. Eur. Respir. J. https:\/\/doi.org\/10.1183\/13993003.00970-2022 (2023).","journal-title":"Eur. Respir. J."},{"key":"48502_CR33","doi-asserted-by":"publisher","first-page":"e0257016","DOI":"10.1371\/journal.pone.0257016","volume":"16","author":"JM Arthur","year":"2021","unstructured":"Arthur, J. M. et al. Development of ACE2 autoantibodies after SARS-CoV-2 infection. PLoS One 16, e0257016. https:\/\/doi.org\/10.1371\/journal.pone.0257016 (2021).","journal-title":"PLoS One"},{"key":"48502_CR34","doi-asserted-by":"publisher","first-page":"fcaa069","DOI":"10.1093\/braincomms\/fcaa069","volume":"2","author":"K Ritchie","year":"2020","unstructured":"Ritchie, K., Chan, D. & Watermeyer, T. The cognitive consequences of the COVID-19 epidemic: Collateral damage?. Brain Commun. 2, fcaa069. https:\/\/doi.org\/10.1093\/braincomms\/fcaa069 (2020).","journal-title":"Brain Commun."},{"key":"48502_CR35","doi-asserted-by":"publisher","first-page":"e0254347","DOI":"10.1371\/journal.pone.0254347","volume":"16","author":"ML Bell","year":"2021","unstructured":"Bell, M. L. et al. Post-acute sequelae of COVID-19 in a non-hospitalized cohort: Results from the Arizona CoVHORT. PLoS One 16, e0254347. https:\/\/doi.org\/10.1371\/journal.pone.0254347 (2021).","journal-title":"PLoS One"},{"key":"48502_CR36","doi-asserted-by":"publisher","first-page":"100122","DOI":"10.1016\/j.lanepe.2021.100122","volume":"6","author":"M Augustin","year":"2021","unstructured":"Augustin, M. et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: A longitudinal prospective cohort study. Lancet Reg. Health Eur. 6, 100122. https:\/\/doi.org\/10.1016\/j.lanepe.2021.100122 (2021).","journal-title":"Lancet Reg. Health Eur."},{"key":"48502_CR37","doi-asserted-by":"publisher","first-page":"ofab640","DOI":"10.1093\/ofid\/ofab640","volume":"9","author":"MJ Peluso","year":"2022","unstructured":"Peluso, M. J. et al. Persistence, magnitude, and patterns of postacute symptoms and quality of life following onset of SARS-CoV-2 infection: Cohort description and approaches for measurement. Open Forum Infect. Dis. 9, ofab640. https:\/\/doi.org\/10.1093\/ofid\/ofab640 (2022).","journal-title":"Open Forum Infect. Dis."},{"key":"48502_CR38","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jpsychires.2022.10.045","volume":"156","author":"JB Zawilska","year":"2022","unstructured":"Zawilska, J. B. & Kuczynska, K. Psychiatric and neurological complications of long COVID. J. Psychiatr. Res. 156, 349\u2013360. https:\/\/doi.org\/10.1016\/j.jpsychires.2022.10.045 (2022).","journal-title":"J. Psychiatr. Res."},{"key":"48502_CR39","doi-asserted-by":"publisher","first-page":"2164498","DOI":"10.1080\/21642850.2022.2164498","volume":"11","author":"ML Goodman","year":"2023","unstructured":"Goodman, M. L., Molldrem, S., Elliott, A., Robertson, D. & Keiser, P. Long COVID and mental health correlates: A new chronic condition fits existing patterns. Health Psychol. Behav. Med. 11, 2164498. https:\/\/doi.org\/10.1080\/21642850.2022.2164498 (2023).","journal-title":"Health Psychol. Behav. Med."},{"key":"48502_CR40","unstructured":"Clinical spectrum of SARS-CoV-2 Infection. NIH https:\/\/www.covid19treatmentguidelines.nih.gov\/overview\/clinical-spectrum\/. (2023)."},{"key":"48502_CR41","unstructured":"Global COVID-19 clinical platform case report form (CRF) for Post COVID condition (Post COVID-19 CRF), WHO Global COVID-19 Clinical Platform Case Report Form (CRF) for Post COVID condition (Post COVID-19 CRF) (who.int) (2021)."},{"key":"48502_CR42","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s11136-009-9496-9","volume":"18","author":"RD Hays","year":"2009","unstructured":"Hays, R. D., Bjorner, J. B., Revicki, D. A., Spritzer, K. L. & Cella, D. Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items. Qual. Life Res. 18, 873\u2013880. https:\/\/doi.org\/10.1007\/s11136-009-9496-9 (2009).","journal-title":"Qual. Life Res."},{"key":"48502_CR43","unstructured":"PROMIS\u00ae score cut points, HealthMeasures https:\/\/www.healthmeasures.net\/score-and-interpret\/interpret-scores\/promis\/promis-score-cut-points (2021)."},{"key":"48502_CR44","doi-asserted-by":"publisher","first-page":"l1476","DOI":"10.1136\/bmj.l1476","volume":"365","author":"B Levis","year":"2019","unstructured":"Levis, B., Benedetti, A., Thombs, B. D. & Collaboration, D. E. S. D. Accuracy of Patient Health questionnaire-9 (PHQ-9) for screening to detect major depression: Individual participant data meta-analysis. BMJ 365, l1476. https:\/\/doi.org\/10.1136\/bmj.l1476 (2019).","journal-title":"BMJ"},{"key":"48502_CR45","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jad.2016.12.012","volume":"210","author":"A Hinz","year":"2017","unstructured":"Hinz, A. et al. Psychometric evaluation of the generalized anxiety disorder screener GAD-7, based on a large German general population sample. J. Affect. Disord. 210, 338\u2013344. https:\/\/doi.org\/10.1016\/j.jad.2016.12.012 (2017).","journal-title":"J. Affect. Disord."},{"key":"48502_CR46","doi-asserted-by":"publisher","first-page":"113598","DOI":"10.1016\/j.psychres.2020.113598","volume":"295","author":"N Kar","year":"2021","unstructured":"Kar, N., Kar, B. & Kar, S. Stress and coping during COVID-19 pandemic: Result of an online survey. Psychiatry Res. 295, 113598. https:\/\/doi.org\/10.1016\/j.psychres.2020.113598 (2021).","journal-title":"Psychiatry Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-48502-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-48502-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-48502-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T13:06:35Z","timestamp":1702299995000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-48502-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,11]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["48502"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-48502-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,11]]},"assertion":[{"value":"27 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21971"}}